Inhibidores de la angiogénesis en el tratamiento del cáncer
Leído
10829
Vecesse ha leído el artículo
9838
Total PDF
991
Total HTML
Información del artículo
ISSN: 15781550Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 6 | 29 | 35 |
| 2025 11 | 8 | 78 | 86 |
| 2025 10 | 10 | 60 | 70 |
| 2025 9 | 12 | 57 | 69 |
| 2025 8 | 15 | 53 | 68 |
| 2025 7 | 11 | 53 | 64 |
| 2025 6 | 9 | 78 | 87 |
| 2025 5 | 9 | 82 | 91 |
| 2025 4 | 8 | 129 | 137 |
| 2025 3 | 12 | 135 | 147 |
| 2025 2 | 8 | 127 | 135 |
| 2025 1 | 8 | 112 | 120 |
| 2024 12 | 5 | 51 | 56 |
| 2024 11 | 8 | 71 | 79 |
| 2024 10 | 6 | 69 | 75 |
| 2024 9 | 7 | 86 | 93 |
| 2024 8 | 8 | 79 | 87 |
| 2024 7 | 6 | 73 | 79 |
| 2024 6 | 4 | 69 | 73 |
| 2024 5 | 10 | 120 | 130 |
| 2024 4 | 10 | 76 | 86 |
| 2024 3 | 16 | 98 | 114 |
| 2024 2 | 9 | 94 | 103 |
| 2024 1 | 12 | 84 | 96 |
| 2023 12 | 7 | 79 | 86 |
| 2023 11 | 5 | 136 | 141 |
| 2023 10 | 8 | 143 | 151 |
| 2023 9 | 4 | 153 | 157 |
| 2023 8 | 5 | 114 | 119 |
| 2023 7 | 5 | 94 | 99 |
| 2023 6 | 7 | 148 | 155 |
| 2023 5 | 8 | 233 | 241 |
| 2023 4 | 4 | 87 | 91 |
| 2023 3 | 2 | 63 | 65 |
| 2023 2 | 2 | 75 | 77 |
| 2022 1 | 4 | 67 | 71 |
| 2022 12 | 5 | 92 | 97 |
| 2022 11 | 8 | 120 | 128 |
| 2022 10 | 6 | 77 | 83 |
| 2022 9 | 9 | 99 | 108 |
| 2022 8 | 6 | 59 | 65 |
| 2022 7 | 8 | 73 | 81 |
| 2022 6 | 6 | 41 | 47 |
| 2022 5 | 9 | 87 | 96 |
| 2022 4 | 13 | 71 | 84 |
| 2022 3 | 10 | 93 | 103 |
| 2022 2 | 5 | 73 | 78 |
| 2021 1 | 7 | 131 | 138 |
| 2021 12 | 5 | 101 | 106 |
| 2021 11 | 8 | 132 | 140 |
| 2021 10 | 12 | 82 | 94 |
| 2021 9 | 7 | 88 | 95 |
| 2021 8 | 12 | 76 | 88 |
| 2021 7 | 10 | 87 | 97 |
| 2021 6 | 8 | 61 | 69 |
| 2021 5 | 10 | 44 | 54 |
| 2021 4 | 20 | 66 | 86 |
| 2021 3 | 7 | 165 | 172 |
| 2021 2 | 12 | 115 | 127 |
| 2020 1 | 6 | 108 | 114 |
| 2020 12 | 3 | 104 | 107 |
| 2020 11 | 3 | 130 | 133 |
| 2020 10 | 5 | 102 | 107 |
| 2020 9 | 6 | 100 | 106 |
| 2020 8 | 8 | 101 | 109 |
| 2020 7 | 7 | 75 | 82 |
| 2020 6 | 3 | 77 | 80 |
| 2020 5 | 4 | 142 | 146 |
| 2020 4 | 3 | 90 | 93 |
| 2020 3 | 5 | 93 | 98 |
| 2020 2 | 6 | 66 | 72 |
| 2020 1 | 13 | 110 | 123 |
| 2019 12 | 13 | 100 | 113 |
| 2019 11 | 3 | 87 | 90 |
| 2019 10 | 6 | 77 | 83 |
| 2019 9 | 6 | 92 | 98 |
| 2019 8 | 1 | 48 | 49 |
| 2019 7 | 7 | 79 | 86 |
| 2019 6 | 30 | 158 | 188 |
| 2019 5 | 49 | 210 | 259 |
| 2019 4 | 12 | 198 | 210 |
| 2019 3 | 2 | 134 | 136 |
| 2019 2 | 3 | 112 | 115 |
| 2019 1 | 0 | 67 | 67 |
| 2018 12 | 2 | 63 | 65 |
| 2018 11 | 5 | 74 | 79 |
| 2018 10 | 3 | 24 | 27 |
| 2018 9 | 2 | 29 | 31 |
| 2018 8 | 2 | 47 | 49 |
| 2018 7 | 3 | 40 | 43 |
| 2018 6 | 2 | 39 | 41 |
| 2018 5 | 2 | 77 | 79 |
| 2018 4 | 2 | 62 | 64 |
| 2018 3 | 1 | 46 | 47 |
| 2018 2 | 1 | 47 | 48 |
| 2018 1 | 2 | 37 | 39 |
| 2017 12 | 1 | 28 | 29 |
| 2017 11 | 0 | 68 | 68 |
| 2017 10 | 5 | 32 | 37 |
| 2017 9 | 1 | 39 | 40 |
| 2017 8 | 3 | 60 | 63 |
| 2017 7 | 2 | 54 | 56 |
| 2017 6 | 5 | 122 | 127 |
| 2017 5 | 3 | 124 | 127 |
| 2017 4 | 10 | 81 | 91 |
| 2017 3 | 11 | 128 | 139 |
| 2017 2 | 3 | 139 | 142 |
| 2016 1 | 1 | 26 | 27 |
| 2016 12 | 4 | 28 | 32 |
| 2016 11 | 3 | 90 | 93 |
| 2016 10 | 6 | 77 | 83 |
| 2016 9 | 9 | 51 | 60 |
| 2016 8 | 7 | 23 | 30 |
| 2016 7 | 5 | 5 | 10 |
| 2016 2 | 0 | 1 | 1 |
| 2015 10 | 0 | 1 | 1 |
| 2015 8 | 0 | 1 | 1 |
| 2015 7 | 0 | 4 | 4 |
| 2015 4 | 0 | 1 | 1 |
| 2015 3 | 2 | 3 | 5 |
| 2015 2 | 2 | 1 | 3 |
| 2015 1 | 1 | 5 | 6 |
| 2014 12 | 1 | 3 | 4 |
| 2014 11 | 2 | 2 | 4 |
| 2014 10 | 1 | 1 | 2 |
| 2014 9 | 3 | 0 | 3 |
| 2014 8 | 5 | 3 | 8 |
| 2014 7 | 8 | 1 | 9 |
| 2014 6 | 14 | 2 | 16 |
| 2014 5 | 11 | 0 | 11 |
| 2014 4 | 0 | 1 | 1 |
| 2004 8 | 150 | 0 | 150 |
Mostrar todo